Adrenocortical function is often impaired in patients with severe asthma, particularly those using oral steroids. This adrenal suppression may contribute to mortality in acute asthma cases.
Area of Science:
Endocrinology
Pulmonology
Pharmacology
Background:
Acute severe asthma is a critical condition requiring prompt management.
Adrenocortical function is crucial for stress response and overall homeostasis.
Previous studies have suggested a link between corticosteroid use and adrenal suppression, but data in acute severe asthma is limited.
Purpose of the Study:
To assess adrenocortical function in patients with acute severe asthma.
To investigate the impact of different corticosteroid regimens on adrenal suppression.
To determine if adrenal insufficiency is a significant factor in asthma-related mortality.
Main Methods:
Intravenous short synacthen test (SST) was administered to 68 patients with acute severe asthma and 22 control subjects.
Serum cortisol levels were measured before and after synacthen stimulation to assess cortisol increment.
Patients were categorized based on their steroid use (continuous oral, occasional oral, inhaled, or no steroids).
Serum dehydroepiandrosterone sulfate (DHEA-SO4) levels were also analyzed.
Main Results:
Subnormal cortisol increment was observed in 19 of 68 asthmatic patients (28%).
Adrenal suppression was most pronounced in patients on continuous oral steroids (11/14) and those on divided daily oral steroid doses (19/43).
Patients on inhaled steroids only (1/7) or no steroids (0/18) showed less frequent adrenal suppression.
Serum DHEA-SO4 levels were not a reliable indicator of adrenocortical function in this cohort.
A significant proportion of patients with low cortisol increments had not received supplementary steroids prior to admission.
Conclusions:
Adrenocortical function is frequently impaired in patients with acute severe asthma, particularly those with a history of oral corticosteroid use.
The degree of adrenal suppression correlates with the intensity and duration of oral steroid therapy, especially divided daily doses.
Adrenal insufficiency may represent an underrecognized contributor to mortality in patients with acute severe asthma, particularly in regions like New Zealand.